We found that K-Pα(+)S KS cells treated with PDGFR tyrosine kinase inhibitor lost their ability to continue proliferating upon KSHV lytic reactivation while showing increased levels of senescence markers. The gene discussed is LRP1; the disease is Kaposi's sarcoma.